Wolverine Trading’s Intersect ENT, Inc XENT Stock Holding History

Wolverine Trading’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,300	Closed	-$143K	–	5492
2020 Q1	$143K	Buy	+12,300	New	+$273K	﹤0.01%	3858
2019 Q4	–	Sell	-10,500	Closed	-$174K	–	5436
2019 Q3	$174K	Sell	10,500 -20,500	-66%	-$373K	﹤0.01%	3651
2019 Q2	$706K	Sell	31,000 -11,400	-27%	-$307K	﹤0.01%	2362
2019 Q1	$1.36M	Buy	+42,400	New	+$1.31M	﹤0.01%	1816
2018 Q4	–	Sell	-37,800	Closed	-$1.09M	–	5643
2018 Q3	$1.09M	Buy	+37,800	New	+$1.14M	﹤0.01%	2265
2017 Q3	–	Sell	-13,600	Closed	-$368K	–	5265
2017 Q2	$368K	Buy	+13,600	New	+$308K	﹤0.01%	2752

Other funds holding XENT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wolverine Trading's XENT Position: Q2 2020 in Review

Wolverine Trading sold out of Intersect ENT, Inc (XENT) in Q2 2020, closing a stake of 11,016 shares — an estimated $128K sold.

Wolverine Trading first reported a position in XENT in Q1 2017 and held it in 5 quarters. The position peaked at $341K in Q4 2017. 108 funds tracked by Wall St. Rank hold XENT as of Q2 2020.

Wolverine Trading reported no remaining Intersect ENT, Inc position as of Q2 2020 after selling out during the quarter.
Wolverine Trading sold 11,016 Intersect ENT, Inc shares in Q2 2020, an estimated $128K.
Wolverine Trading first reported a position in Intersect ENT, Inc in Q1 2017 and held it in 5 quarters.
Wolverine Trading's Intersect ENT, Inc position peaked at $341K in Q4 2017.
108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.